Dual targeted hit identification using pharmacophore screening

Tuesday, 18 February 2020

Recently, the article dedicated to the development of dual-targeted inhibitors of mycobacterial aminoacyl-tRNA synthetases using pharmacophore screening has been...

Dual-target inhibitors of mycobacterial aminoacyl-tRNA synthetases among N-benzylidene-N'-thiazol-2-yl-hydrazines

Tuesday, 18 February 2020

Recently, the article dedicated to the development of dual-targeted inhibitors of mycobacterial aminoacyl-tRNA synthetases among N-benzylidene-N'-thiazol-2-yl-hydrazines has been...

Benzaldehyde thiosemicarbazone derivatives against replicating and nonreplicating Mycobacterium tuberculosis

Tuesday, 28 May 2019

Recently, the article dedicated to the development of antituberculosis agents based on benzaldehyde thiosemicarbazone derivatives has been published.

Abstract:

In this article, we...

Participation in FEBS 2018 Advanced Courses "Ligand-binding theory and practice"

Sunday, 15 July 2018

Young scientist from the Department of Medicinal Chemistry of the Institute of Molecular Biology and Genetics of the NAS of Ukraine, Galyna Volynets, participated in FEBS Advanced Course...

News and Events

Dual targeted hit identification using pharmacophore screening

Dual-target inhibitors of mycobacterial aminoacyl-tRNA synthetases among N-benzylidene-N'-thiazol-2-yl-hydrazines

Benzaldehyde thiosemicarbazone derivatives against replicating and nonreplicating Mycobacterium tuberculosis

Participation in FEBS 2018 Advanced Courses "Ligand-binding theory and practice"

Our research:

CK2 Inhibitors

ASK1 Inhibitors

FGFR1 Inhibitors

Fluorescent Probes

Molecular Design